GENSAIC Trademark

Trademark Overview


On Tuesday, May 24, 2022, a trademark application was filed for GENSAIC with the United States Patent and Trademark Office. The USPTO has given the GENSAIC trademark a serial number of 97425330. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 1, 2024. This trademark is owned by M13 Therapeutics Inc.. The GENSAIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, pharmaceuticals for the treatment of cancer, metabolic diseases, cardiovascular diseases, neurological diseases, age-related diseases, immunological diseases, and genetic diseases, pharmaceuticals for the treatment of diseases and disorders with genetic etiology, gene therapies, and nucleic acid therapies; house mark for pharmaceutical preparations for human use, namely, pharmaceuticals for the treatment of cancer, metabolic diseases, cardiovascular diseases, neurological diseases, age-related diseases, immunological diseases, and genetic diseases, pharmaceuticals for the treatment of diseases and disorders with genetic etiology, gene therapies, and nucleic acid therapies; pharmaceutical preparations for veterinary use, namely, pharmaceuticals for the treatment of cancer; house mark for pharmaceutical preparations for veterinary use, namely, pharmaceuticals for the treatment of cancer and age-related disease; cosmeceuticals, namely, me...
gensaic

General Information


Serial Number97425330
Word MarkGENSAIC
Filing DateTuesday, May 24, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use, namely, pharmaceuticals for the treatment of cancer, metabolic diseases, cardiovascular diseases, neurological diseases, age-related diseases, immunological diseases, and genetic diseases, pharmaceuticals for the treatment of diseases and disorders with genetic etiology, gene therapies, and nucleic acid therapies; house mark for pharmaceutical preparations for human use, namely, pharmaceuticals for the treatment of cancer, metabolic diseases, cardiovascular diseases, neurological diseases, age-related diseases, immunological diseases, and genetic diseases, pharmaceuticals for the treatment of diseases and disorders with genetic etiology, gene therapies, and nucleic acid therapies; pharmaceutical preparations for veterinary use, namely, pharmaceuticals for the treatment of cancer; house mark for pharmaceutical preparations for veterinary use, namely, pharmaceuticals for the treatment of cancer and age-related disease; cosmeceuticals, namely, medicated skin and hair care preparations; house mark for cosmeceuticals, namely, medicated skin and hair care preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGENSAIC, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02420

Party NameGENSAIC, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02420

Party NameM13 Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02420

Trademark Events


Event DateEvent Description
Friday, May 27, 2022NEW APPLICATION ENTERED
Tuesday, May 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 13, 2023ASSIGNED TO EXAMINER
Tuesday, March 14, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 14, 2023NON-FINAL ACTION E-MAILED
Tuesday, March 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 14, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, June 14, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, August 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 18, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 27, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 27, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, September 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 27, 2023EXAMINER'S AMENDMENT ENTERED
Friday, September 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 17, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, November 23, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, November 24, 2023NON-FINAL ACTION WRITTEN
Friday, November 24, 2023NON-FINAL ACTION E-MAILED
Friday, November 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 27, 2023TEAS PETITION TO DIRECTOR RECEIVED
Thursday, February 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024SUSPENSION LETTER WRITTEN
Thursday, February 29, 2024LETTER OF SUSPENSION E-MAILED
Thursday, February 29, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 1, 2024ASSIGNED TO PETITION STAFF
Thursday, April 4, 2024PETITION TO DIRECTOR GRANTED
Wednesday, August 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED